| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.097 | 0.04 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.04 |